Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes

MLA

Laura M. Jacobsen, et al. “Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes.” Diabetes Care, vol. 45, Dec. 2021, pp. 311–18. EBSCOhost, https://doi.org/10.2337/dc21-0944.

APA

Laura M. Jacobsen, Brandon M. Nathan, Maria J. Redondo, Susan Geyer, Laura E. Bocchino, Jerry P. Palmer, Heba M. Ismail, Jay S. Skyler, Emily K. Sims, & Jay M. Sosenko. (2021). Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes. Diabetes Care, 45, 311–318. https://doi.org/10.2337/dc21-0944

Chicago

Laura M. Jacobsen, Brandon M. Nathan, Maria J. Redondo, Susan Geyer, Laura E. Bocchino, Jerry P. Palmer, Heba M. Ismail, Jay S. Skyler, Emily K. Sims, and Jay M. Sosenko. 2021. “Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes.” Diabetes Care 45 (December): 311–18. doi:10.2337/dc21-0944.